- Home
- IOVA vs SVM Comparison
IOVA vs SVM Comparison
Compare IOVA & SVM Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- IOVA
- SVM
- Stock Information
- Founded
- IOVA 2007
- SVM N/A
- Country
- IOVA United States
- SVM Canada
- Employees
- IOVA N/A
- SVM N/A
- Industry
- IOVA Biotechnology: Biological Products (No Diagnostic Substances)
- SVM Precious Metals
- Sector
- IOVA Health Care
- SVM Basic Materials
- Exchange
- IOVA Nasdaq
- SVM Nasdaq
- Market Cap
- IOVA 771.4M
- SVM 906.7M
- IPO Year
- IOVA N/A
- SVM N/A
- Fundamental
- Price
- IOVA $1.88
- SVM $5.14
- Analyst Decision
- IOVA Buy
- SVM Strong Buy
- Analyst Count
- IOVA 10
- SVM 1
- Target Price
- IOVA $12.22
- SVM $6.75
- AVG Volume (30 Days)
- IOVA 10.5M
- SVM 7.0M
- Earning Date
- IOVA 08-07-2025
- SVM 08-12-2025
- Dividend Yield
- IOVA N/A
- SVM 0.49%
- EPS Growth
- IOVA N/A
- SVM 40.00
- EPS
- IOVA N/A
- SVM 0.28
- Revenue
- IOVA $212,679,000.00
- SVM $298,895,000.00
- Revenue This Year
- IOVA $86.62
- SVM $1.10
- Revenue Next Year
- IOVA $69.95
- SVM $26.47
- P/E Ratio
- IOVA N/A
- SVM $19.15
- Revenue Growth
- IOVA 11070.12
- SVM 38.90
- 52 Week Low
- IOVA $1.64
- SVM $2.87
- 52 Week High
- IOVA $12.51
- SVM $5.32
- Technical
- Relative Strength Index (RSI)
- IOVA 47.47
- SVM 71.35
- Support Level
- IOVA $1.68
- SVM $4.45
- Resistance Level
- IOVA $2.02
- SVM $4.94
- Average True Range (ATR)
- IOVA 0.11
- SVM 0.20
- MACD
- IOVA 0.03
- SVM 0.06
- Stochastic Oscillator
- IOVA 61.42
- SVM 99.58
About IOVA Iovance Biotherapeutics Inc.
Iovance Biotherapeutics Inc is a clinical-stage biopharmaceutical company, pioneering a transformational approach to treating cancer by harnessing the human immune system's ability to recognize and destroy diverse cancer cells using therapies personalized for each patient. The company is preparing for potential U.S. regulatory approvals and commercialization of the first autologous T-cell therapy to address a solid tumor cancer. its objective is to be the leader in innovating, developing, and delivering tumor-infiltrating lymphocyte, or TIL, therapies for patients with solid tumor cancers.
About SVM Silvercorp Metals Inc.
Silvercorp Metals Inc is a mineral exploration company, engaged in the acquisition, exploration, development, and mining of mineral properties. The company's producing mines are located in China, and exploration and development projects are located in China and Ecuador. Its project portfolio comprises the El Domo copper-gold and the Condor gold project in Ecuador. In addition, it operates several silver-lead-zinc mines at the Ying Mining District in Henan Province, China, and the GC silver-lead-zinc mine in Guangdong Province, China. A majority of the company's revenue is generated through the sale of silver concentrates. Its reportable operating segments are the Ying Mining District and GC Mine in China, which derive maximum revenue, and the El Domo and Condor projects in Ecuador.